IDT Biologika Vaccine Facility Recognized

IDT Biologika, a contract manufacturer of biopharmaceuticals and vaccines, has announced it is the recipient of the 2015 Facility of the Year Award (FOYA) for facility integration. The award, sponsored by the International Society for Pharmaceutical Engineering, spotlights companies that set the standard in pharmaceutical facility design, integration and operational excellence.

The company completed an expansion of its biologics and vaccines production facility in Germany in 2014, adding automated filling and freeze-drying operations for large-scale commercial manufacturing and increased quality of aseptic operations.

A manufacturer of human vaccines, IDT Biologika expanded vaccine production from two to three buildings and extended its capacities for large scale commercial production of new human vaccines. The company can manufacture up to 100 million vials per year of freeze-dried and liquid presentations.

An automated loading and unloading freeze-dryer system affords the company a key position for vaccine manufacturing services, the company reports in a press statement. Other features include a freeze-dryer shelf capacity of 40 m2, equal to at maximum 178,000 vials per batch, particle and microbiological tests, repeated camera inspections, 100% fill volume controls, vial coding and washing of capped vials.

A new isolator filling line can be expanded with two additional 40 m2 freeze-dryers for scaled-up commercial supply. The building concept allows the implementation of an additional filling line to effectively double manufacturing capacity upon request.

The International Society for Pharmaceutical Engineering will formally recognize IDT Biologika for facility integration along with winners in other categories during the Facility of the Year Awards Banquet, June 2, 2015, in Washington, D.C.

Source: IDT Biologika